No Seroconversion for Anti-Β2GPI Antibodies in Patients Treated With Prometic’s Intravenous Immunoglobulin 10% Solution

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.345
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy